Healthy volunteers help test skin absorption of common immune drug
NCT ID NCT03673527
First seen May 01, 2026 · Last updated Jun 14, 2026 · Updated 10 times
Summary
This early-stage study tested how much of the drug tacrolimus gets into the bloodstream when applied twice daily to healthy skin. Twenty-four healthy adults took part. The goal was to measure drug levels and check for side effects, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational site
Neu-Ulm, Bavaria, 89231, Germany
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.